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Abstract
Background: HIV-associated neurocognitive disorder (HAND) is a neurodegenerative disease associated with
persistent neuroinflammation and subsequent neuron damage. Pro-inflammatory factors and neurotoxins from
activated astrocytes by HIV-1 itself and its encoded proteins, including the negative factor (Nef), are involved
in the pathogenesis of HAND. This study was designed to find potential lncRNAs that regulate astrocyte
functions and inflammation process.
Methods: We performed microarray analysis of lncRNAs from primary mouse astrocytes treated with Nef protein.
Top ten lncRNAs were validated through real-time PCR analysis. Gene ontology (GO) and KEGG pathway analysis
were applied to explore the potential functions of lncRNAs. RIP and ChIP assays were performed to demonstrate
the mechanism of lncRNA regulating gene expression.
Results: There were 638 co-upregulated lncRNAs and 372 co-downregulated lncRNAs in primary astrocytes
treated with Nef protein for both 6 h and 12 h. GO and KEGG pathway analysis showed that the biological
functions of top differential-expressed mRNAs were associated with inflammatory cytokines and chemokine.
Knockdown of lncRNA AK006025, not AK138360, inhibited significantly CXCL9, CXCL10 (IP-10), and CXCL11
expression in astrocytes treated with Nef protein. Mechanism study showed that AK006025 associated with
CBP/P300 was enriched in the promoter of CXCL9, CXCL10, and CXCL11 genes.
Conclusions: Our findings uncovered the expression profiles of lncRNAs and mRNAs in vitro, which might
help to understand the pathways that regulate astrocyte activation during the process of HAND.
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Background
Human immunodeficiency virus type 1 (HIV-1) infection
has been demonstrated to be associated with HIV-asso-
ciated neurocognitive disorders (HAND) that is charac-
terized by degenerative loss of neurons and ultimately
develops into HIV-associated dementia (HAD), the most
severe form of HAND [1, 2]. Despite the use of highly
active antiretroviral therapy (HAART) has successfully
prevented many of the former end-stage complications
of acquired immunodeficiency syndrome (AIDS), neur-
onal cell death remains a problem that is frequently
found in the brains of HIV-1-infected patients. With
prolonged survival of AIDS patients, the prevalence of
minor cognitive motor disorder appears to be rising
among AIDS patients. Furthermore, HAD is still preva-
lent in treated AIDS patients.
HAND pathogenesis is associated with the direct and
indirect effects of HIV-1 infection on the neuron damage
and loss [3]. The direct effects from HIV-1 infection in
the central nervous system (CNS) are from the neurotox-
icity of HIV-1 itself [4–6] and HIV-1-encoded proteins in-
cluding gp120 [7–10], transactivator of transcription (Tat)
[3, 11–14], and negative factor (Nef) [15, 16], whereas the
indirect toxicity is due to altered glutamate neurotrans-
mission [5], as well as pro-inflammatory cytokines that are
secreted by astrocytes or microglia infected with HIV-1 or
stimulated with HIV-1 proteins [3, 17].
Astrocytes, the major glial cell type within the CNS [18],
support neuron function through promoting formation
and function of synapses and build the formation of the
blood-brain barrier (BBB) [19]. Furthermore, astrocytes
possess the capacity to interact with the peripheral im-
mune system by recruiting leukocytes and monocytes into
the CNS [20]. Reactive astrocytosis is an important feature
in an inflammatory condition that occurs during HAND
pathology [21]. Experimental data indicate that astrocyte
activation is involved in the pathogenesis of HAND char-
acterized by an increased expression of pro-inflammatory
cytokines and chemokine [3, 17]. In response to HIV-1
and its encoded protein, Nef, in the CNS, astrocytes in-
crease chemokine production to facilitate T cells and
monocytes recruitment to the CNS [17]. However, the
mechanisms by which astrocyte activation contribute to
HAND by Nef remain still unknown.
Nef is a 27-kDa myristoylated protein released from
HIV-infected cells in the exosome manner [22–24]. Nef
interacts with a multitude of cellular factors and func-
tions in trafficking, signal transduction, and gene expres-
sion. Nef leads to neural cell death directly and
indirectly through the production of CXCL10 (IP-10)
[25]. Functionally, Nef expressed in astrocytes results in
impairing spatial and recognition memory in rats [26].
Clinical data display that Nef expresses in hippocampal
neurons in HIV+ patients with HAD [27], consistent
with this protein being involved in the memory impair-
ment of those individuals. Of important, HIV-1 Nef in-
duces CCL5 production in astrocytes to promote neuron
death through p38-MAPK and PI3K/Akt pathway and
utilization of transcription factors, such as NF-κB, C/
EBP, and AP-1 [16]. These exciting results have
prompted us to scan the expression profiles of inflam-
matory cytokines and chemokine in astrocytes induced
by Nef and their roles in HAND pathogenesis.
Long non-coding RNAs (lncRNAs) have been defined
as RNA transcripts more than 200 nucleotides in length
that do not encode proteins. Based on the lncRNA-related
position in the genome to the protein-coding genes,
lncRNAs include five categories, which are sense, anti-
sense, intronic, intergenic, and bidirectional [28]. Emer-
ging evidence suggests that they play key roles in various
biological and physiological processes including chromatin
remodeling, epigenetic regulation, RNA splicing, and pro-
tein transport and directly relate to human diseases in-
cluding neurodegenerative disorders [29–32]. One of the
major functions of lncRNAs appears to be in the epigen-
etic regulation of gene transcription [32]. For example,
lncRNAs have been shown to associate with a plethora of
epigenetic modifier complexes including PRC2, PRC1,
Cbx1, Cbx3, Tip60/P400, Setd8, ESET and Suv39h1, Jar-
id1b, Jarid1c, HDAC1, and YY1 [33, 34]. It has been re-
ported that lncRNA H19 promotes neuroinflammation in
ischemic stroke by driving HDAC1-dependent M1 micro-
glial polarization [35]. In addition, lncRNAs activate
NF-κB and MAP kinase pathway to regulate inflammation
gene expression [36–39]. However, the roles of lncRNAs
in the process of HAND are still unknown.
CREB-binding protein (CBP)/P300, histone acetyltrans-
ferase (HAT), is transcription co-activator that is cis-regula-
tory elements to control patterns of gene expression. By the
enzymatic activity localized in HAT domain, CBP/P300 tar-
get both histones and numerous transcriptional factors
(TFs), leading to elevated histone 3 lysine 27 acetylation
(H3K27ac), p53, NF-κB, and RNA Pol II acetylation that
forms a transcription network “hub” to promote gene ex-
pression [40–45]. Recent data show that CBP/P300 binds
directly to enhancer RNAs (eRNAs) to stimulate histone
acetylation and gene transcription [46]. Moreover, lncRNAs
bind CBP/P300 activity to regulate gene expression [47].
In the present study, we analyzed the lncRNA and
mRNA expression landscape of astrocytes treated by Nef
protein in vitro. Our results suggest potential roles of
lncRNAs in regulating inflammation in astrocytes during
the process of HAND.
Methods
Animals
C57BL/6 mice were obtained from Nanjing University
Laboratory Animal Center. Mice were housed at 25 ± 1 °
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C with 55–65% humidity and maintained under specific
pathogen-free conditions. All experimental procedures
described in our study were performed according to the
Provision and General Recommendation of the Chinese
Laboratory Association. The protocol was approved by
the Institutional Animal Care and Use Committee of
Xuzhou Medical University.
Primary astrocyte culture
Primary mouse astrocytes from 0- to 1-day-old C57BL/6
mice were established as previously described [48]. In
brief, the cerebral cortices freed of meninges were dis-
sected, minced, and digested. After washed twice in
DMEM/F12 medium containing 10% fetal bovine serum
(FBS), the cells were filtrated, transferred to culture flasks
pre-coated with 1 mg/ml poly-L-lysine (Sigma), and then
cultured at 37 °C with 5% CO2. Cells were passed for three
passages and then glial fibrillary acidic protein (GFAP,
astrocytic marker) expression was analyzed using im-
munofluorescence assays (IFA). Finally, at least 95%
GAFP+ cells were used to research.
Primary human astrocytes were obtained from ScienCell
Research Laboratories with the help of Shanghai Zhong
Qiao Xin Zhou Biotechnology Co., Ltd. in China. Human
astrocytes were cultured in the Astrocyte Medium (AM,
Cat. No. 1801) contained 2% FBS (Cat. No. 0010) and
astrocyte growth supplement (AGS, Cat. No. 1852) at 37 °
C with 5% CO2. Cells were passed for three passages and
performed to research.
RNA extraction
Total RNA was extracted from the primary astrocytes
according to manufactures instructions. RNA quantity
and quality was measured using NanoDrop ND-1000
spectrophotometer (Thermo Fisher Scientific).
Determination of lncRNA and mRNA profiles
The expression profiles of lncRNAs and mRNAs were de-
tected as previously described [49]. Primary mouse astro-
cytes treated with 50 ng/ml Nef protein (Abcam, ab90462)
were detected using Mouse LncRNA Microarray v2.0 (8 ×
60 K, Arraystar) by Kangchen Bio-tech (Shanghai, China)
that designed for the global profiling of mouse LncRNAs
and protein-coding transcripts. Thirty-one thousand four
hundred twenty-three LncRNAs and 25,376 coding tran-
scripts can be detected by the second-generation LncRNA
microarray. The LncRNAs are carefully collected from the
most authoritative databases such as RefSeq, UCSC
Known Genes, Ensembl, and many related literatures.
Each transcript is represented by a specific exon or splice
junction probe which can identify accurately individual
transcript. Positive probes for housekeeping genes and
negative probes are also printed onto the array as
hybridization quality control.
According to previous experimental project, microarray
assays had also been performed using pooled plasma,
blood, liver, heart, or cell samples [50]. RNAs from mixed
astrocytes treated with Nef protein three times were run
microarray analysis. The acquired raw array images were
processed by Agilent Feature Extraction software (version
11.0.1.1) and then normalized and analyzed by the Gene-
Spring GX v12.0 software package (Agilent Technologies).
Differentially expressed lncRNAs and mRNAs were then
identified through fold change as well as P values calcu-
lated with t test. The threshold for up and downregulation
was fold change > 2.0 and P value < 0.05. Afterwards, hier-
archical clustering was performed to display the distin-
guishable lncRNA and mRNA expression patterns among
the samples.
Real-time PCR assay
Real-time PCR (real-time PCR) assay was detected as pre-
viously described [49]. In brief, the total RNA from cul-
tured astrocytes was extracted with TRIzol reagent
(Invitrogen). First-strand cDNAs were generated using
PrimeScriptTM RT reagent kit (TaKaRa, Japan), and SYBR
Premix Ex TaqTM based on real-time PCR (TaKaRa) was
performed to analyze the relative expression levels of
lncRNAs and mRNAs. The relative gene expression was
calculated using the 2 −ΔΔCT method. The primers are
listed in Additional file 1: Table S1.
Functional group analysis of mRNAs
Gene ontology (GO) and KEGG analysis were applied to
determine the functions of differentially expressed
mRNAs in biological pathways using the standard enrich-
ment computation method [49]. The P value (hypergeo-
metric P value) denotes the significance of the pathway
correlated to the conditions. The recommend P value cut-
off is 0.05.
ELISA
The levels of Cxcl9, Cxcl10, and Cxcl11 in the superna-
tants of cultured astrocytes were detected using Mouse
ELISA kits (Abcam) according to the manufacturer’s
instructions.
RNA immunoprecipitation (RIP) assay
RIP assay was performed as previously described [51].In
brief, after treated with Nef protein, 2 × 107 primary
mouse astrocytes were treated with 0.3% formaldehyde
in DMEM/F12 medium for 10 min at 37 °C. Glycine dis-
solved in PBS (1.25 M) was added to the final concentra-
tion of 0.125 M for 5 min at room temperature (RT).
Cells were then washed twice in cold PBS and pelleted.
The pellets were resuspended in RIPA buffer and incu-
bated on ice with frequent vortex for 30 min, and the
lysate was centrifugated at 13,000 RPM for 10 min.
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Antibodies (5 μg) were added and incubated for 4 h at 4 °
C. Samples were washed twice in RIPA buffer, four times
in 1 M RIPA buffer, and then twice in RIPA in spin col-
umns. The beads were resuspended in RIPA buffer and
treated with proteinase K at 45 °C for 45 min. RNA sam-
ples were extracted with Trizol. Co-precipitated RNAs
were purified with the RNeasy Mini Kit (QIAGEN) and
detected by real-time PCR. The data of retrieved RNAs is
calculated from the subtraction of RT/input ratio and
non-RT/input ratio. The primer sequence was listed in
Additional file 1: Table S1.
Chromatin immunoprecipitation (ChIP) assay
ChIP assays were performed as described previously [52].
Briefly, primary mouse astrocytes were treated with or
without Nef protein for 3 h. Cells were cross-linked with
1% formaldehyde (final concentration) for 10 min at RT
and then stopped by 1.25 mM of glycine (final concentra-
tion). 1 × 107 cells were used for each ChIP-enrichment.
Chromatin was sheared to the fragment size of 200–
500 bp using a Bioruptor (Diagenode). The antibodies
used in the ChIP experiments were anti-NF-κB p65 anti-
body (Cell Signaling Technologies), anti-H3K27ac anti-
body (Abcam), anti-RNA Pol II antibody (Active Motif),
anti-CBP/P300 antibody (Cell Signaling Technologies),
normal mouse IgG (Santa Cruz). All immunoprecipitated
chromatin DNA was analyzed by real-time PCR. The pri-
mer sequences were listed in Additional file 1: Table S1.
Knockdown of lncRNAs
To silence the mouse lncRNA AK006025 and AK138360,
siRNA sequences against AK006025 and AK138360 were
designed. siRNA sequences were as follows: si-Ctrl,
5′-UUC UCC GAA CGU GUC ACG UTT-3′; si-
AK006025, 5′-GCT GGG AAC CCA CAC ATA A-3′ and
si-AK138360, 5′-GCA CCG GGC AAT GTT TAAT-3′.
Statistical analysis
SPSS version 18.0 was used for the statistical analysis of
experimental data. Data presented as mean ± standard
error of mean (SEM), calculated for all points from at
least three independent experiments in triplicates. Statis-
tical significance was determined using the two-tailed
Student’s t test or by one-way analysis of variance
(ANOVA) when more than two groups were compared.
P < 0.05 was considered significant.
Fig. 1 Identification of differentially expressed mRNAs in primary mouse astrocytes treated with Nef protein. a Heatmap of mRNAs significantly
changed upon Nef (50 ng/ml) stimulation of astrocytes. b, c, d Scatter plot compared global mRNA gene expression profiles in Nef-
treated astrocytes. The values of X-axis and Y-axis in the scatter plot were the normalized signal values of each sample (log2 scaled). The
green lines are fold change (the default fold change value given is 2.0). The mRNAs above the top green line and below the bottom
green line indicate more than 2.0-fold change, compared to the control. e Analysis of numbers of significantly expressed mRNAs. f
Overlapped and differentially expressed mRNAs
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Results
Differentially expressed mRNA in the primary mouse
astrocytes treated with Nef protein
To detect differentially expressed mRNAs in the activated
mouse primary astrocytes, we performed a genome-wide
analysis of mRNA expression profiles in the astrocytes
stimulated with Nef protein (50 ng/ml) at the different
time point (Fig. 1a). Firstly, a graphical overview of the ex-
pression signatures of mRNAs was performed by scatter
plot analyses. The result displayed that a great number of
mRNAs were differentially expressed in the astrocytes
with Nef protein at 0 h, 6 h, and 12 h (Fig. 1b, c). Mean-
while, many mRNAs were differentially co-expressed in
the astrocytes with Nef protein at 6 h and 12 h (Fig. 1d).
We then analyzed altered expression of mRNAs with
fold change > 2, the criteria P value < 0.05 in the astro-
cytes stimulated by Nef protein at 6 h and 12 h com-
pared with 0 h, respectively. Results showed that 734
mRNAs were upregulated, and 876 mRNAs were down-
regulated in the astrocytes stimulated by Nef protein for
6 h (Fig. 1e) and that 1077 upregulated and 980 down-
regulated mRNAs for 12 h (Fig. 1e). Notably, there were
460 co-upregulated and 376 co-downregulated mRNAs
for between 6 h and 12 h (Fig. 1f ). Importantly, there
were many inflammatory cytokines and chemokine,
especially highly expressed Cxcl11, Cxcl10 (IP-10), Cxcl9,
Cxcl3, Cxcl2, Cxcl1, Ccl5, Il-1β, Il-6, and Tnf, among the
co-upregulated mRNAs (Table 1).
To confirm the role of Nef protein in chemokine ex-
pression in human astrocytes, human primary astrocytes
were treated with Nef protein for 6 h, CXCL9, CXCL10,
and CXCL11 mRNA levels were determined by real-time
PCR assay. The results showed that mRNA levels of
CXCL9, CXCL10, and CXCL11 were significantly in-
creased in human astrocytes treated with Nef at 6 h and
12 h (Fig. 2a), which was inconsistent with mouse astro-
cytes. To further determine upregulated mouse Cxcl9,
Cxcl10, and Cxcl11 by soluble recombinant Nef protein
rather than by other factors like lipopolysaccharide (LPS),
mouse primary astrocytes were immunoeluted with Nef
(iNef) protein through using anti-Nef antibody (Abcam,
ab42355) pretreatment prior to Nef stimulation for 6 h.
Real-time PCR assay indicated that iNef did not induce
mRNA levels of Cxcl9, Cxcl10, and Cxcl11 (Fig. 2b). These
results suggest that Nef itself enhances CXCL11, CXCL10,
and CXCL9 expression in human and mouse astrocytes.
Go and KEGG pathway analysis of the molecular function
of differentially expressed genes
To further explore potential molecular mechanism in
HAND pathogenesis, GO and KEGG pathway analysis was
performed for differentially expressed genes in astrocytes
treated with Nef protein. GO analysis showed that the mo-
lecular function (MF) of differentially co-upregulated
expressed transcripts was associated with cytokine and
chemokine activity as well as their receptor binding in as-
trocytes treated with Nef protein (Fig. 3a). Furthermore,
differentially co-downregulated genes were mainly related
with protein binding in astrocytes treated with Nef protein
(Fig. 3b).
KEGG pathway analysis indicated that 40 pathways were
significantly involved in differentially expressed genes. Up-
regulated genes were enriched in cytokine and its receptor
interaction, chemokine signaling pathway, NF-κB signal-
ing pathway, and so on (Fig. 3c). Downregulated genes
were involved in metabolism, lysosome, CoA biosynthesis,
insulin signaling pathway, etc. (Fig. 3d). The above data
represent that HAND is associated with the mRNA
changes of inflammatory factors in the astrocytes.
Differentially expressed lncRNA in the primary mouse
astrocytes treated with Nef protein
We further determined differentially expressed lncRNAs
in the astrocytes treated with Nef protein at the different
time point (Fig. 4a). Scatter plot analyses were firstly
used to scan the expression signatures of lncRNAs. The
result showed that a large number of lncRNAs were dif-
ferentially expressed in the astrocytes with Nef protein
at 0 h, 6 h, and 12 h (Fig. 4b, c). Meanwhile, lots of
Table 1 Top 20 overlapped and upregulated mRNAs in mouse
astrocytes treated with Nef protein (50 ng/ml) for 6 h and 12 h
Gene symbol Upregulated folds
6 h/0 h 12 h/0 h
Cxcl11 105.05796 473.09506
Cxcl9 43.443104 213.93571
Ifnb1 112.73581 154.63144
Il1b 54.497185 153.78612
Gm4841 52.749744 149.3729
Cxcl2 98.37795 131.17091
Irg1 69.53818 101.9587
Ccl5 39.71899 94.32046
Il6 21.031158 74.925606
Ccl7 27.82146 74.49636
Fam26f 11.689228 64.880646
Cd69 30.492313 53.828453
Cxcl10 37.51984 45.796886
Cxcl1 20.680431 45.20861
Il1a 13.884002 49.921574
Cxcl3 38.239742 43.34039
Tnfsf10 4.3851957 24.53629
Tnf 30.36271 24.412766
Ccl3 11.2570715 15.065439
Ccl2 9.46433 10.722074
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lncRNAs were differentially expressed in the astrocytes
with Nef protein at 12 h, compared to 6 h (Fig. 4d).
We then analyzed the differential expression of
lncRNAs in the astrocytes stimulated by Nef protein at
6 h and 12 h compared with 0 h, respectively. Results
showed that 1358 lncRNAs were upregulated, and 670
lncRNAs were downregulated in the astrocytes stimu-
lated by Nef protein for 6 h (Fig. 4e) and that 1534 up-
regulated and 1271 downregulated lncRNAs for 12 h
(Fig. 4e). Notably, there were 638 co-upregulated and
372 co-downregulated lncRNAs for both 6 h and 12 h
(Fig. 4f ). The list of the top 20 differentially expressed
Fig. 2 Determination of effects of Nef protein on CXCL9/10/11 gene expression. a Primary human astrocytes were treated with soluble
Nef protein (50 ng/ml) for 6 h and 12 h. Human CXCL9, CXCL10, and CXCL11 mRNA levels were determined by real-time PCR assay (n =
3). Error bars represent means ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, vs 0 h. b Primary mouse astrocytes were pre-treated with different
concentration of anti-Nef antibody followed by soluble Nef protein (50 ng/ml) for 6 h. Mouse Cxcl9, Cxcl10, and Cxcl11 mRNA levels were
determined by real-time PCR assay (n = 3). Error bars represent means ± SEM. *P < 0.05, ***P < 0.001, vs NT. ##P < 0.01, ###P < 0.001, vs Nef
Fig. 3 Biological function of differentially overlapped genes with fold changes more than 2.0. a, b GO analysis of significant molecular function of
co-upregulated and co-downregulated genes were shown in primary mouse astrocytes treated by Nef protein (50 ng/ml) with 6 h and 12 h. c, d
KEGG pathway analysis of significant pathways for co-upregulated and co-downregulated genes were shown in primary mouse astrocytes treated
by Nef protein with 6 h and 12 h
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lncRNAs for both 6 h and 12 h identified by microarray
analysis was shown in Additional file 1: Table S2 and
Table 2.
Validation of the microarray data using real-time PCR
To further verify the accuracy of microarray data, we
randomly assigned 10 lncRNAs from the differentially
expressed lncRNAs, including 5 co-upregulated (Gm16685,
Gm12250, AK151815, AK139352, and Gm8773) and 5
co-downregulated (AK038606, Gm12326, AK039511,
Gm13484, and AK043126) and tested their expression
through real-time PCR assay. As shown in Fig. 5,
Gm16685, Gm12250, AK151815, AK139352, and Gm8773
expression were significantly increased, whereas AK038606,
Gm12326, AK039511, Gm13484, and AK043126 expres-
sion were obviously decreased in the astrocytes stimulated
by Nef protein for 6 h and 12 h, compared with 0 h. Over-
all, these data confirmed the accuracy of microarray data.
Analysis of upregulated lncRNAs on the chromosome 5 in
the primary mouse astrocytes treated with Nef protein
Then, we analyze differentially co-upregulated lncRNAs
on chromosome 5 in the primary mouse astrocytes
treated with Nef protein for 6 h and 12 h. As shown in
Table 2, ten lncRNAs were selected as targeted ones. All
of them were located at two terminals of Cxcl3/2/1 gene
cluster and Cxcl/10/11 gene cluster (Additional file 1:
Table S2). Among them, Uc008xxt.1 and AK138360
were close to 5′ terminal of Cxcl3/2/1 gene cluster while
AK148399 and AK006025 were nearby the 3′ terminal
of the Cxcl9/10/11 gene cluster (Fig. 6a). The class dis-
tribution of AK138360 and AK006025 were intergenic,
Uc008xxt.1 was sense-overlap, and AK148399 was bidir-
ectional (Additional file 1: Table S3).
We further measured above lncRNAs expression by
real-time PCR in primary astrocytes stimulated with Nef
protein. Results of real-time PCR showed that Uc008xxt.1,
AK138360, AK148399, and AK006025 were significantly
regulated (Fig. 6b), which was in accordance with the
microarray data.
Knockdown of lncRNA AK006025 repressed Cxcl9/10/11
cluster gene expression
Intergenic lncRNA, as an in cis-regulatory element, reg-
ulates gene expression. To determine the role of inter-
genic lncRNAs in regulating Cxcl9/10/11 cluster gene
expression, siRNA of AK138360 or AK006025 was
transfected into primary mouse astrocytes for 48 h,
Fig. 4 Analysis of differentially expressed lncRNAs in primary mouse astrocytes treated with Nef protein. a Heatmap of lincRNAs significantly
changed upon Nef (50 ng/ml) stimulation of astrocytes. b, c, d Scatter plot compared global lncRNA expression profiles in Nef-treated
astrocytes. The values of X-axis and Y-axis in the scatter plot were the normalized signal values of each sample (log2 scaled). The green
lines are fold change (the default fold change value given is 2.0). The mRNAs above the top green line and below the bottom green
line indicate more than 2.0-fold change, compared to the control. e Analysis of numbers of significantly expressed lncRNAs. f Overlapped
and differentially expressed lncRNAs
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followed by Nef protein treatment for 6 h and 12 h, re-
spectively. We detected Cxcl9/10/11 expression using
ELISA and real-time PCR. As seen from Fig. 7a, siRNA
of AK138360 or AK006025 inhibited their expression.
All of Cxcl9, Cxcl10, and Cxcl11 expression were signifi-
cantly decreased in mouse astrocytes treated with Nef
protein after knockdown of AK006025, not AK138360
(Fig. 7b).
AK006025 associated with CBP/P300 regulates Nef-
induced Cxcl9/10/11 cluster gene expression
To further uncover the potential mechanism how
lncRNA AK006025 regulated Cxcl9/10/11 cluster gene
expression, RIP assay was used for detecting lncRNA
AK006025 and NF-κB p65 and/or CBP/P300 interaction.
RIP results showed that AK006025 was significantly as-
sociated with NF-κB p65 and CBP/P300 in mouse astro-
cytes treated with Nef protein for 3 h (Fig. 8a).
Furthermore, ChIP assay indicated that NF-κB p65,
CBP/P300, RNA Pol II, and H3K27ac were differentially
enriched in in the promoter Cxcl9/10/11 gene cluster in
mouse astrocytes treated with Nef protein for 3 h
(Fig. 8b). Of importance, siRNA of AK006025 repressed
dramatically NF-κB p65 and CBP/P300 enrichment in
the promoter Cxcl9/10/11 gene cluster in mouse astro-
cytes treated with Nef protein for 3 h (Fig. 8c). The data
suggest that the interaction of AK006025 and CBP/P300
may regulate epigenetically Cxcl9/10/11 cluster gene
transcription.
Discussion
HAND is a degenerative disease of the central nervous
system with chronic inflammation, synapse dysfunction,
and neuron loss. Many studies have determined that the
blockade of pro-inflammatory cytokine and chemokine
production in astrocytes could protect the neuron dam-
age of HAND pathogenesis [13, 16, 17].
Nef, a myristoylated protein encoded by HIV-1, func-
tions in the multifaceted biological process including
trafficking, signal transduction, and gene expression in a
paracrine manner. Nef is released from infected cells
into the plasma of HIV-infected individuals [53]. The de-
tectable concentration of soluble Nef in the serum
ranges from 1 to 10 ng/ml [54, 55]. The soluble Nef can
be taken up by several types of cells to regulate cellular
function, such as B cells, primary effusion lymphoma
(PEL) cells, pulmonary arterial endothelial cells as well
as primary human umbilical vein endothelial cells
(HUVECs) [56–59]. Although HIV-1 built latency in as-
trocytes in the brain, the expression of HIV-1 genes are
low, for example, HIV p24 in HIV-1 + postmortem brain
astrocytes is rarely detected [60]. Therefore, we used sol-
uble Nef protein as an exogenous factor to explore its
role in inducing the expression of lncRNAs and mRNAs.
Here, our data showed that the exogenous Nef protein
enhanced CCL5 and IP-10 expression in astrocytes,
consistent with previous data of endogenous Nef ex-
pression [16, 25].
Over the past decades, the molecular mechanisms
underlying HAND have been extensively explored.
However, the understanding of the pathophysiological
process of HAND is still limited. In recent years, a
large number of evidence shows that lncRNAs have
been associated with human diseases, such as cancer,
neurological disorders, and so on [30, 31, 52, 61].
LncRNAs are found as important regulators of neuro-
development and brain function [31]. However, there
is no knowledge that lncRNAs are associated with a
particular molecular or cellular function in HAND patho-
genesis. To date, the functional characterization of
lncRNAs during the HAND/HAD process and astro-
cyte activation has not been uncovered. Our recent
study demonstrated the expression profiles of lncRNAs
in Nef-treated astrocytes, analyzed the co-expression of
lncRNAs in vivo and in vitro, and explored their char-
acteristics and possible relations with protein-coding
genes.
Table 2 Top 20 overlapped and upregulated lncRNAs in mouse
astrocytes stimulated with Nef protein (50 ng/ml) for 6 h and
12 h
lncRNA seqname Length Upregulated folds
6 h/0 h 12 h/0 h
Gm16685 1592 33.808704 98.312874
Gm5970 1216 11.263321 75.315765
Gm12250 1274 6.2884264 61.74965
AK085771 1165 6.540899 66.45514
uc008roq.1 3961 45.042114 58.77
Gm4955 913 6.5966477 50.151352
A530040E14Rik 1262 10.544557 50.162678
Gm12407 720 6.1827254 33.648342
Gm13309 324 6.142315 30.465094
Mx2 2428 12.378684 37.599354
AK151815 1592 7.3327208 26.562384
MM9LINCRNAEXON11240- 1100 10.792236 20.239393
uc008smk.1 701 6.23503 32.482025
ENSMUST00000160565 1414 3.362174 22.119934
AK139352 4337 6.970084 36.466106
AK145170 2791 9.817351 20.934488
ENSMUST00000135659 1443 14.289103 18.727198
NR_003507 1848 3.7799745 14.091469
Gm8773 1268 5.3409157 10.783084
uc008zif.1 704 2.7248611 12.014651
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In our study, we found that there were 1385 upregulated
lncRNAs and 734 upregulated mRNAs in the astrocytes
stimulated by Nef protein for 6 h; meanwhile, 670
lncRNAs and 876 mRNAs were downregulated. Further-
more, 1534 lncRNAs and 1077 mRNAs were upregulated,
and 1271 lncRNAs and 982 mRNAs were downregulated
in the astrocytes stimulated by Nef for 6 h. Of importance,
there were 638 lncRNAs and 460 mRNAs that differen-
tially co-upregulated, and 372 lncRNAs and 376 mRNAs
that differentially co-downregulated in the astrocytes
treated with Nef for both 6 h and 12 h. Moreover,
real-time PCR assay was performed to confirm parts of
differentially expressed lncRNAs and mRNAs, which was
consistent with the results of lncRNAs microarray.
Interestingly, the differentially-expressed lncRNAs appear
to have a relationship with the levels of inflammatory cy-
tokines and chemokine secreted by astrocytes, suggesting
that these lncRNAs might uncover novel insight into the
molecular basis of HAND pathogenesis.
In our studies, a large number of inflammatory genes
were significantly co-upregulated in the astrocytes
treated with Nef for both 6 h and 12 h, especially
Cxcl11, Cxcl10, Cxcl9, Cxcl3, Cxcl2, Cxcl1, Ccl5, Il-1β,
Il-6, and Tnf. Furthermore, some mRNAs including
Ifnb1, Irg1, Tnfsf10, and CD69 were also screened out
and dramatically increased (Table 1), whose functions
are associated with immune response, interferon (IFN)
signal as well as apoptosis. Therefore, further studies
Fig. 5 Real-time PCR verification of differentially co-expressed lncRNAs in astrocytes stimulated with Nef. Ten lncRNAs were randomly chosen for
real-time PCR validation. a The expressions of lncRNA Gm16685, Gm12250, AK151815, AK139352, and Gm8773 were significantly increased in
astrocytes stimulated with Nef protein (50 ng/ml) with 0 h, 6 h, and 12 h. b The expressions of lncRNA AK038606, Gm12326, AK039511, Gm13484,
and AK043126 were markedly downregulated in astrocytes. *P < 0.05, **P < 0.01, ***P < 0.001, vs 0 h. Error bars represent means ± SEM. These data
are from three independent experiments
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are needed to demonstrate whether they are involved in
HAND process.
CXC chemokine, structurally recognizable by the pos-
ition of four conserved cysteine residues, are prominent
mediators of chemotaxis. The Cxcl9/10/11 genes locate
on the mouse chromosome 5 in cluster manner and are
induced by IFN [62]. Previous data showed that Nef in-
creased IP-10 expression in astrocytes [25]. Here, we
scanned the chemokine expression profile in primary
mouse astrocytes treated with Nef protein. The result
showed that Cxcl9, Cxcl10, and Cxcl11 were all top dif-
ferentially expressed; of importance, Nef increased
CXCL9, CXCL10, and CXCL11, mRNA levels in human
astrocytes, which suggests an important role in HAND
pathogenesis.
Emerging data show that lncRNAs are involved in
regulating NF-κB signaling, anti-viral response, and in-
flammatory response [36–39, 47]. In the present study,
based on the GO term enrichment and pathway maps of
mRNAs, we found that markedly enriched molecular
functions and biological processes of upregulated genes
in astrocytes were mainly associated with cytokine and
chemokine activity as well as their receptor binding in
astrocytes treated with Nef protein. These findings are
consistent with previous data showing that the infiltra-
tion of immune cells and inflammation play a vital role
in the pathogenesis of HAND [17].
It has been established that lncRNAs have been shown
to link a number of epigenetic modified complexes with
transcriptional factors including NF-κB, resulting in
regulating gene expression [33, 34, 36]. In addition,
lncRNAs bind CBP/P300 activity to regulate gene ex-
pression [47]. Here, we analyzed four lncRNAs located
on 5′ terminal and 3′ terminal of Cxcl3/2/1 gene cluster
and Cxcl9/10/11 gene cluster. Among them, AK138360
and AK006025 siRNA located on 3′ terminal of the
Cxcl9/10/11 gene cluster. Unexpectedly, all of Cxcl9,
Cxcl10, and Cxcl11 expression were dramatically de-
creased in mouse astrocytes treated with Nef protein
after knockdown of AK006025, not AK138360. Further-
more, RIP and ChIP assay showed that AK006025 asso-
ciated with NF-κB p65 and CBP/P300 was enriched in
the promoter of Cxcl9, Cxcl10, and Cxcl11. These data
suggest that interaction of AK006025 and CBP/P300
might regulate epigenetically Cxcl9/10/11 cluster gene
transcription in HAND pathogenesis.
So far, our findings still have several limitations. First
of all, these studies only were performed to scan lncRNA
profiles in primary mouse astrocytes, which is possibly
different from that of human astrocytes, particularly for
ncRNAs that are heterogeneous expressions in mouse
cells. Secondly, we only determined the role of a single
acute exposure to Nef protein, which may differ from
the effects of chronic exposure in HAND pathogenesis.
Fig. 6 Verification of lncRNA location at two terminals of CXCL9/10/11 gene cluster on the mouse chromosome 5. a Schematic diagram
of lncRNA location at two terminals of CXCL9/10/11 gene cluster. b Real-time PCR assay detection of lncRNA expression in astrocytes
treated with Nef protein (50 ng/ml) with 0 h, 6 h, and 12 h. *P < 0.05, **P < 0.01, ***P < 0.001, vs 0 h. Error bars represent means ± SEM.
These data are from three independent experiments
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Fig. 7 Knockdown of lncRNA AK006025 reduced CXCL9/10/11 cluster gene expression in astrocytes treated with Nef. a Real-time PCR
assay detection of lncRNA expression in astrocytes transfected siRNAs for 48 h, followed by treatment with Nef protein for 6 h and 12 h.
b Real-time PCR assay analysis of CXCL9, CXCL10, and CXCL11 mRNA transcriptional level in astrocytes transfected siRNAs for 48 h, followed by
treatment with Nef protein for 12 h. c ELISA analysis of CXCL9, CXCL10, and CXCL11 secretion in astrocytes transfected siRNAs for 48 h,
followed by treatment with Nef protein for 24 h. *P < 0.05, **P < 0.01, ***P < 0.001, vs 0 h. Error bars represent means ± SEM. These data
are from three independent experiments
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Therefore, it is important to demonstrate how Nef in-
fluences lncRNAs expression in human astrocytes in
HAND.
Conclusion
In summary, our results revealed that Nef induced
thousands of differentially expressed lncRNAs in astro-
cytes. LincRNA AK006025 was involved in regulating
Nef-induced CXCL9, CXCL10, and CXCL11 expression
through interaction with NF-κB p65 and CBP/P300,
which may play key roles in neuroinflammation and
pathogenesis of HAND.
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Table S2. Top 20 overlapped and downregulated lncRNAs in mouse
astrocytes stimulated with Nef protein (50 ng/ml) for 6 h and 12 h. Table
S3. Analysis of differentially upregulated lncRNAs on the chromosome 5
in the mouse astrocytes stimulated with Nef protein (50 ng/ml) for 6 h
and 12 h. (DOC 118 kb)
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